TW432036B - 4-mercaptobenzoylguanidine derivatives - Google Patents

4-mercaptobenzoylguanidine derivatives Download PDF

Info

Publication number
TW432036B
TW432036B TW085100660A TW85100660A TW432036B TW 432036 B TW432036 B TW 432036B TW 085100660 A TW085100660 A TW 085100660A TW 85100660 A TW85100660 A TW 85100660A TW 432036 B TW432036 B TW 432036B
Authority
TW
Taiwan
Prior art keywords
module
tested
light
structures
test device
Prior art date
Application number
TW085100660A
Other languages
English (en)
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus-Otto Minck
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of TW432036B publication Critical patent/TW432036B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Testing Resistance To Weather, Investigating Materials By Mechanical Methods (AREA)

Description

M432036 五、新型說明: 【新型所屬之技術領域】 本創作係關於一種光浸满測試裝置,詳言之,係關於一 種承載平台具有中空導管結構之光浸潤測試裝置。 【先前技術】 參考圖1 ’顯示習知光浸潤測試裝置之剖視示意圖。該 光浸潤測試裝置1包括一光源、一承載平台12、一冷卻氣 體提供裝置及一支撐裝置18。該光源係用以提供光線10。 該承載平台1 2係用以承載一待測試模組14,該待測試模組 14具有一第一表面141及一第二表面142。來自該光源之光 線10係照射該待測試模組丨4之第一表面141。 该承載平台12具有一第一表面121、一第二表面122及複 數個透孔I23。該等透孔丨”係係由該第一表面121貫穿至 該第二表面122,且係陣列排列。該冷卻氣體提供裝置係 提供一冷卻氣體16,該冷卻氣體16穿過該等透孔123至該 φ 待測"式模組14之第二表面142 ’以冷卻該待測試模組14。 該支撐裝置18係用以支擇該待測試模組14 ,使得該待測試 模組14之第二表面142與該承載平台12之第一表面121間隔 -預設距離,而形成一空間19,以供該冷卻氣體Μ流動。 由於該待測試模組14係為—太陽能電池模組,且該光線 10係為模擬太陽井之本砼 /+ _ 元之先線,使得在測試過程_該待測 組14受到該光線10持續照射而導致其溫度會十分高,因此 需要該冷卻氣體16持續從該待測試模組14之第 帶走熱能。 159885.doc ”作時’位於該空間19中間區域之氣流必須向外 排出’因此,发户你去 、 /、在移動過程中會影響到外圍區域之氣流。 亦即,中0 _ 域之冷卻氣體已被加熱後(此時形成為高溫 氣體)再向外软& y合 移動’外圍區域之冷卻氣體遇到該高溫氣體 炎曰先升之後才接觸到該待測試模組Μ之第二表面 此會導致該待測試模組14在中間位置之溫度較 低而越接近邊緣之溫度越高。因此,該待測試模組14之 溫:十分不均句,其測試結果之可靠度降低。 因此’有必要提供—種光浸潤測試裝置,以解決上述問 題0 【新型内容】 =乍提供:種光浸潤測試裝置,其包括一光源、一承 〃 σ及冷部氣體提供裝置。㈣源係用 該承載平台係用以在并 係照射該待測試榲相。。 . 乂九源之光線 個中*導;^、、· “承载平台具有複數個透孔及複數 該等中空導管結構係連通該等透孔,且 彼此間隔一間隙, & tu _a_ έβ 〇 a - - ^巾冑$管結構係®對該待測試模 該等中空導管姓構至^ 氣體穿過該等透孔及 試模組。,、、。構至該待測試模組’以均勻地冷卻該待測 藉此,該冷卻氣體離 直接接觸到該待測試模.之第結構之上端後皆可 體混合’以確保該待測試模組之第二表= Γ 接受到低溫之冷卻氣體 品:白可 «使得垓待測試模組之每 159885.doc 塊區域之溫度十分均勻,以提高其測試結果之可靠度。 【實施方式】 請參考圖2,顯示本創作光浸潤測試裝置之一實施例之 剖視示意圖《該光浸潤測試裝置2包括一光源(圖中未示)、 一承載平台22、一冷卻氣體提供裝置(圖中未示)及一支撐 裝置28。 該光源係用以提供光線20。在本實施例中,該光源係提 供模擬太陽光之光線20 ;然而在其他實施例中,該光源係 提供其他種類之光線20。該承載平台22係用以承載一待測 試模組24,該待測試模組24具有一第一表面241及一第二 表面242。來自該光源之光線2〇係照射該待測試模組以之 第一表面241。在本實施例中,該待測試模組以係為一太 陽旄電池模組,然而在其他實施例中,該待測試模組24係 為其他種類之模組。 該承載平台22具有一第一表面221、一第二表面222、複 數個透孔223及複數個中空導管結構3〇β該等透孔223係係 由該第一表面221貫穿至該第二表面222,且係陣列排列。 該等中空導管結構30係連通該等透孔223,且係陣列排列 同時彼此間隔一間隙3 01。在本實施例中,該等中空導管 結構30係位於該承載平台22之第一表面221,且面對該待 測試模組24。 該冷卻氣體提供裝置係提供一冷卻氣體26,該冷卻氣體 26穿過該等透孔223及該等中空導管結構3〇至該待測試模 組24之第二表面242 ’以均勻地冷卻該待測試模組24。該 159885.doc 么。裝1: 28係用以支樓該待測試模組24,使得該待測試模 組24之第二表面242與該承載平台22之第-表面221間隔- 預設距離,而形成—空間29,以供該冷卻氣體%流動。可 以理解的是,料中空導管結構30之高度係略小於該空間 29之南度。 參考圖3,顯示本創作中承載平台之一實施例之立體 不意圖。在本實施例中,該等中空導管結構Μ係陣列排 列且彼此間隔一間隙3〇1。每_中空導管結構係為一 單一筒體,且固設(例如:焊接)於該承載平台22之第一表 面221上。在本實施例中’每_中空導管結構μ之橫截面 =為方形;然而在其他實施例中,每—中空導管結構3〇之 橫截面可以是其他形狀,例如:圓形。 在該光浸潤測試裝置2之實際操作時,每一中空導管結 構30之上端與該待測試模組24之第二表面242間之距離= 短,因此該冷卻氣體26離開每一中空導管結構3〇之上端後 會在此處形成一高壓區;相對地,該間隙3〇ι則形成一低 壓區》當該冷卻氣體26接觸該待測試模組24之第二表面 242被加熱後形成一高溫氣體32後,該高溫氣體32接著會 進入該低壓區(即該間隙301)才被排出。亦即’該高壓區及 該低壓區形成一壓差,可避免該高溫氣體32進入其他位置 之高壓區。因此,該冷卻氣體26離開每一中空導管結構3〇 之上端後皆可直接接觸到該待測試模組24之第二表面242 而不會與該高溫氣體32混合,以確保該待測試模組24之第 二表面242之母塊區域皆可接受到低溫之冷卻氣體μ。藉 159885.doc -6- 此’會使得該待測試模組24之每塊區域之溫度十分均句, 以提高其測試結果之可靠度。 請參考圖4,顯示本創作中承載平台之另—實施例之立 體示意圖。請參考圖5’顯示圖4之承載平台之中空導管結 構之立體分解示意圖。在本實施例中,每—中空導管結構 30a包括-第-筒體3〇2及—第二筒體3()3。該第二筒體3〇3 係固設(例如:焊接)於該承載平台22之第一表面221上。該 第一筒體302之長度係大於該第二筒體3〇3,且套設於該第 二筒體303上。在本實施例中,該第一筒體3〇2及該第二筒 體3 03之杈戴面係為圓形;然而在其他實施例中,該第一 筒體302及該第二筒體3〇3之橫截面可以是其他形狀,例 如:方形。 上述實施例僅為說明本創作之原理及其功效,並非限制 本創作。因此習於此技術之人士對上述實施例進行修改及 變化仍不脫本創作之精神。本創作之權利範圍應如後述之 申6青專利範圍所列。 【圖式簡單說明】 圖1顯示習知光浸潤測試裝置之剖視示意圖; 圖2顯示本創作光浸潤測試裝置之一實施例之剖視示意 園, 圖3顯示本創作中承載平台之一實施例之立體示意圖; 圖4顯示本創作中承載平台之另一實施例之立體示意 圖;及 圖5顯示圖4之承載平台之中空導管結構之立體分解示意 159885.doc M432036 圖 【主要元件符號說明】 1 習知光浸潤測試裝置 2 本創作光浸潤測試裝置之一實施例 10 光線 12 承載平台 14 待測試模組 18 支撐裝置 19 空間 20 光線 22 承載平台 24 待測試模組 26 冷卻氣體 28 支撐裝置 29 空間 30 中空導管結構 30a 中空導管結構 32 南溫氣體 121 承載平台之第一表面 122 承載平台之第二表面 123 透孔 141 待測試模組之第一表面 142 待測試模組之第二表面 221 承載平台之第一表面 I59885.doc M432036 222 承載平台之第二表面 223 透孔 241 待測試模組之第一表面 242 待測試模組之第二表面 301 間隙 302 第一筒體 303 第二筒體
-9- 159885.doc

Claims (1)

  1. M432036 六、申請專利範圍: 1. 一種光浸潤測試裝置,包括: 一光源,用以提供光線; -承載平台’用以承載-待測試模組,來自該光源之 光線係照射該待測試模組,該承載平台具有複數個透孔 及複數個中空導管結構’該等中空導管結構係連通t 透孔,且彼此間隔-間隙,且該等中空導管結構係面對 該待測試模組;及 -冷卻氣體提供裝置,提供一冷卻氣體穿過該等透孔 及該等中空導管結構至該制試模組,以均句地冷卻該 待測試模組。 2. 如請求们之光浸潤測試裝置,其中該光源係提供模擬 太陽光之光線。 3·如請求们之光浸㈣試裝置’其中該待測試模組係為 一太陽能電池模組。 4·=求们之m収裝置,其巾該承載平台具有一 弟-表面及一第二表面’該等透孔係由該第 ★二第一表面,該等令空導管結構係位於該承载平台之 第一表面,且面對該待測試模組。 σ 5·如請求们m職裝置,更包括-錢裝置,用 乂支揮該相試模組,使㈣待測試模組與該承載平台 間隔一預設距離。 α 6 t:求項1之光浸潤測試裝置,其中該等透孔及該等中 空導管結構皆係陣列排列。 寺中 159885.doc •10- M432036 7. 如請求項1之光浸潤測試裝置,其中每一該 結構係為一單一筒體,且固設於該承載平台. 8. 如請求項7之光浸潤測試裝置,其中每一該 結構之橫戴面係為方形。 9. 如請求項1之光浸潤測試裝置,其中每一該 結構包括一第一筒體及一第二筒體,該第二 於該承載平台上,且該第一筒體係套設於 上。 10. 如請求項9之光浸潤測試裝置,其中該第一 二筒體之橫截面係為圓形。 等中空導管 等中空導管 等中空導管 筒體係固設 該第二筒體 筒體及該第 159885.doc -11 -
TW085100660A 1995-01-31 1996-01-20 4-mercaptobenzoylguanidine derivatives TW432036B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19502895A DE19502895A1 (de) 1995-01-31 1995-01-31 4-Mercapto-benzoylguanidin-Derivate

Publications (1)

Publication Number Publication Date
TW432036B true TW432036B (en) 2001-05-01

Family

ID=7752677

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085100660A TW432036B (en) 1995-01-31 1996-01-20 4-mercaptobenzoylguanidine derivatives

Country Status (27)

Country Link
US (1) US5696167A (zh)
EP (1) EP0725062B1 (zh)
JP (1) JP3770947B2 (zh)
CN (1) CN1058001C (zh)
AR (1) AR002954A1 (zh)
AT (1) ATE202088T1 (zh)
AU (1) AU706843B2 (zh)
BR (1) BR9600263A (zh)
CA (1) CA2168319C (zh)
CO (1) CO4700519A1 (zh)
CZ (1) CZ290184B6 (zh)
DE (2) DE19502895A1 (zh)
DK (1) DK0725062T3 (zh)
ES (1) ES2159652T3 (zh)
FI (1) FI960423A (zh)
GR (1) GR3036344T3 (zh)
HU (1) HUP9600213A3 (zh)
NO (1) NO305834B1 (zh)
PL (1) PL181311B1 (zh)
PT (1) PT725062E (zh)
RU (1) RU2162079C2 (zh)
SI (1) SI0725062T1 (zh)
SK (1) SK281199B6 (zh)
TR (1) TR199600067A2 (zh)
TW (1) TW432036B (zh)
UA (1) UA43345C2 (zh)
ZA (1) ZA96701B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (de) 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JP2002530325A (ja) * 1998-11-26 2002-09-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 非インスリン依存型真性糖尿病の治療へのベンゾイルグアニジンの使用
DE19859727A1 (de) 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
DE19951418A1 (de) * 1999-10-26 2001-05-03 Merck Patent Gmbh Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
TWI402261B (zh) 2006-06-19 2013-07-21 Takeda Pharmaceutical 三環化合物及其醫藥組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ATE158278T1 (de) * 1992-02-15 1997-10-15 Hoechst Ag Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
ATE147375T1 (de) * 1992-09-22 1997-01-15 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika
TW250479B (zh) * 1992-12-15 1995-07-01 Hoechst Ag
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
CN1134413A (zh) 1996-10-30
US5696167A (en) 1997-12-09
AR002954A1 (es) 1998-05-27
PL181311B1 (pl) 2001-07-31
NO305834B1 (no) 1999-08-02
DE19502895A1 (de) 1996-08-01
PT725062E (pt) 2001-11-30
DK0725062T3 (da) 2001-09-24
HUP9600213A2 (en) 1997-01-28
JPH08245560A (ja) 1996-09-24
FI960423A0 (fi) 1996-01-30
BR9600263A (pt) 1997-12-23
ATE202088T1 (de) 2001-06-15
EP0725062A1 (de) 1996-08-07
CZ290184B6 (cs) 2002-06-12
JP3770947B2 (ja) 2006-04-26
NO960392L (no) 1996-08-01
RU2162079C2 (ru) 2001-01-20
DE59607055D1 (de) 2001-07-19
AU4220096A (en) 1996-08-08
HU9600213D0 (en) 1996-03-28
CZ27796A3 (en) 1996-10-16
AU706843B2 (en) 1999-06-24
GR3036344T3 (en) 2001-11-30
PL312544A1 (en) 1996-08-05
UA43345C2 (uk) 2001-12-17
CA2168319C (en) 2007-03-06
HUP9600213A3 (en) 1998-07-28
CA2168319A1 (en) 1996-08-01
SK281199B6 (sk) 2001-01-18
CO4700519A1 (es) 1998-12-29
NO960392D0 (no) 1996-01-30
CN1058001C (zh) 2000-11-01
ES2159652T3 (es) 2001-10-16
EP0725062B1 (de) 2001-06-13
SK12896A3 (en) 1996-09-04
TR199600067A2 (tr) 1996-08-21
FI960423A (fi) 1996-08-01
ZA96701B (en) 1997-04-16
SI0725062T1 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
Lee et al. Three-dimensional thermohydrodynamic analyses of Rayleigh step air foil thrust bearing with radially arranged bump foils
Yuan et al. Experimental and numerical investigation of an airflow management system in data center with lower-side terminal baffles for servers
Baytaş et al. Natural convection in a trapezoidal enclosure filled with a porous medium
Pal et al. Influence of chemical reaction and thermal radiation on mixed convection heat and mass transfer over a stretching sheet in Darcian porous medium with Soret and Dufour effects
Nie et al. Numerical and experimental study of three-dimensional fluid flow in the bipolar plate of a PEM electrolysis cell
Liu et al. Numerical simulation and experimental study on the effect of symmetric and asymmetric bionic flow channels on PEMFC performance under gravity
TW432036B (en) 4-mercaptobenzoylguanidine derivatives
Oosthuizen et al. The effect of channel-to-channel gas crossover on the pressure and temperature distribution in PEM fuel cell flow plates
Liu et al. Numerical simulation of a mini PEMFC stack
Zhang et al. Airflow uniformity optimization for modular data center based on the constructal T-shaped underfloor air ducts
Mohebbi-Kalhori et al. Computational modeling of adherent cell growth in a hollow-fiber membrane bioreactor for large-scale 3-D bone tissue engineering
Wei et al. Sensitivity analysis of the battery thermal management system with a reciprocating cooling strategy combined with a flat heat pipe
Yan et al. Numerical study on heat and mass transfer performance of the planar membrane-based humidifier for PEMFC
Lee et al. Comparison of multi-inlet and serpentine channel design on water production of PEMFCs
Xu et al. A battery thermal management scheme suited for cold regions based on PCM and aerogel: Demonstration of performance and availability
Gao et al. Two-stage heat transfer characteristics of constrained melting inside an isothermally heated horizontal cylinder
Ushachew et al. Heat convection in micropolar nanofluid through porous medium-filled rectangular open enclosure: effect of an embedded heated object with different geometries
Chen et al. Thermal performance of cold thermal energy storage system with fin and fin–foam structures
Seddiq et al. Numerical analysis of gas cross-over through the membrane in a proton exchange membrane fuel cell
Inoue et al. Numerical analysis of relative humidity distribution in polymer electrolyte fuel cell stack including cooling water
Lu et al. Dynamics of forward filtration combustion at the pore‐network level
Cheng et al. Thermal behavior and performance of shallow-deep-mixed borehole heat exchanger array for sustainable building cooling and heating
Raguman et al. A review on recent approaches in thermal and water management of polymer electrolyte membrane fuel cells
CN201680118U (zh) 节能隔热型滑动支座
Wang et al. Optimization design method of material stiffness of contact interface considering surface roughness for improving thermal contact performance

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent